foxo4-dri peptide senolytic 2023 study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI Peptide Dosing Guide: Senolytic

Food and Drug Administration (FDA) announced that it will convene a public meeting of the Pharmacy Compounding Advisory Committee (PCAC) on July 23-24, 2026, to consider whether to recommend seven (7) peptide bulk drug substances for inclusion on the list of substances that may be used in compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act

How BPC-157 Supports Safe Recovery Accelerating Tissue Repair BPC-157 enhances angiogenesis (new blood vessel formation) and collagen production, speeding up muscle, tendon, and ligament repair

FDA approval is informative

MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM

The external 8282 address latch (or 74LS373) holds the address stable while those pins carry data, so the memory subsystem sees a clean non-multiplexed interface